Sionna Therapeutics Inc (SION)

10:05 AM

Sionna Therapeutics Inc. Stock Analysis and ForecastRapid capital growth - Autocar Professional

10:05 AM

04:40 AM

Is Sionna Therapeutics Inc. a good long term investmentExplosive market performance - Autocar Professional

04:40 AM

Jul 22, 2025

What analysts say about Sionna Therapeutics Inc. stockDynamic investment growth - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

What drives Sionna Therapeutics Inc. stock priceOutperformance with explosive growth - jammulinksnews.com

Jul 22, 2025

Jul 15, 2025

What makes Sionna Therapeutics Inc. stock price move sharplyFree Access to Community - Newser

Jul 15, 2025

Jul 15, 2025

Why Sionna Therapeutics Inc. stock attracts strong analyst attentionFree Deep Market Trend Analysis - Newser

Jul 15, 2025

Jul 15, 2025

How Sionna Therapeutics Inc. stock performs during market volatilityFree Membership Group - Newser

Jul 15, 2025

Jul 03, 2025

Sionna Therapeutics (NASDAQ:SION) Shares Gap Up on Insider Buying Activity - Defense World

Jul 03, 2025

Jul 01, 2025

Major Investment Alert: Sionna Therapeutics Gains a Boost from TPG GP A, LLC - TipRanks

Jul 01, 2025

Jun 30, 2025

Sionna Therapeutics, Inc.(NasdaqGM: SION) added to Russell Microcap Growth Index - MarketScreener

Jun 30, 2025

Jun 22, 2025

Sionna Therapeutics, Inc.(NasdaqGM: SION) added to S&P Global BMI Index - MarketScreener

Jun 22, 2025

Jun 18, 2025

Sling Therapeutics, Inc. Appoints Ken Lock as Chief Commercial Officer - MarketScreener

Jun 18, 2025

Jun 13, 2025

Sionna Therapeutics reports annual meeting results By Investing.com - Investing.com South Africa

Jun 13, 2025

Jun 13, 2025

Sionna Therapeutics Holds Annual Stockholders Meeting - TipRanks

Jun 13, 2025

Jun 13, 2025

Sionna Therapeutics reports annual meeting results - Investing.com

Jun 13, 2025

Jun 12, 2025

Sionna's experimental CFTR modulators show promise in preclinical tests - Cystic Fibrosis News Today

Jun 12, 2025

Jun 10, 2025

Odyssey Therapeutics pulls plug on IPO plans - The Business Journals

Jun 10, 2025

Jun 10, 2025

Odyssey Ends Quest for Nasdaq, Pulls IPO Application After Nearly 5 Months - BioSpace

Jun 10, 2025

Jun 10, 2025

Odyssey pulls back from IPO plans as public markets remain frozen - Endpoints News

Jun 10, 2025

Jun 06, 2025

Sionna Therapeutics advances CF treatment with new data By Investing.com - Investing.com South Africa

Jun 06, 2025

Jun 06, 2025

Sionna Therapeutics advances CF treatment with new data - Investing.com India

Jun 06, 2025

Jun 06, 2025

Sionna Therapeutics Announces Presentation of Preclinical Data that Demonstrate Proprietary Dual Combination Therapies Enable Full CFTR Correction in CFHBE Model - GlobeNewswire

Jun 06, 2025

Jun 06, 2025

Sionna Therapeutics: A Potential Game-Changer in Cystic Fibrosis Treatment - AInvest

Jun 06, 2025

Jun 05, 2025

NBD1 stabilizers safe in healthy volunteers, Sionna says - Cystic Fibrosis News Today

Jun 05, 2025

Jun 05, 2025

Petri Dish: PepGen halts work on Duchenne drug; Needham biotech announces layoffs - The Business Journals

Jun 05, 2025

Jun 05, 2025

2 Soaring Stocks Wth More Upside Potential - AOL.com

Jun 05, 2025

Jun 05, 2025

Transcript : Sionna Therapeutics, Inc.Special Call - marketscreener.com

Jun 05, 2025

Jun 04, 2025

Sionna advances cystic fibrosis treatments to new trials By Investing.com - Investing.com South Africa

Jun 04, 2025

Jun 04, 2025

Newly-Listed Sionna Therapeutics Touts Positive Data From Lung Disease Candidate In Healthy Volunteer Trial - Benzinga

Jun 04, 2025

Jun 04, 2025

Stifel analysts reiterate buy rating on Sionna Therapeutics stock By Investing.com - Investing.com Canada

Jun 04, 2025

Jun 04, 2025

Sionna Therapeutics Announces Positive Phase 1 Results For SION-719, SION-451 In Cystic Fibrosis - Nasdaq

Jun 04, 2025

Jun 04, 2025

Sionna advances cystic fibrosis treatments to new trials - Investing.com Australia

Jun 04, 2025